Insiders Deciphera Pharmaceuticals, Inc.

Equities

DCPH

US24344T1016

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
14.65 ^USD	+3.31%		-0.14%	-9.18%

Mar. 13	Transcript : Deciphera Pharmaceuticals, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:00 AM
Feb. 06	Deciphera Pharmaceuticals' Q4 Net Loss Narrows, Revenue Rises	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deciphera Pharmaceuticals Insider Sold Shares Worth $259,256, According to a Recent SEC Filing	23-10-31	MT
Deciphera Pharmaceuticals, Inc. Announces Board Changes, Effective from September 5, 2023	23-08-03	CI
Insider Sell: Deciphera Pharmaceuticals	23-03-23	MT
Insider Sell: Deciphera Pharmaceuticals	23-02-16	MT
Deciphera Pharmaceuticals' Q2 Loss Narrows, Revenue Rises	22-08-04	MT
Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Senior Vice President and Chief Business Officer	22-06-16	CI
Margarida Duarte Joins Deciphera Pharmaceuticals, Inc. as Head of International	21-06-03	CI
Deciphera Pharmaceuticals, Inc. Announces Appointment of Margarida Duarte as Senior Vice President, Head of International	21-02-09	CI
Deciphera Pharmaceuticals Announces Appointment of Ron Squarer to its Board of Directors	19-12-04	CI
Deciphera Pharmaceuticals, Inc. Announces Board Changes	19-11-26	CI
Deciphera Pharmaceuticals, Inc. Appoints Matthew L. Sherman as Executive Vice President and Chief Medical Officer	19-10-02	CI
Deciphera Pharmaceuticals, Inc. Appoints Susan L. Kelley, M.D. to the Board	19-07-08	CI
Patricia L. Allen, Edward J. Benz, Jr., James A. Bristol, Michael J. Ross, Michael D. Taylor and Dennis L. Walsh, Directors Not to Stand for Election of Deciphera Pharmaceuticals, Inc	19-04-22	CI
Deciphera Pharmaceuticals, Inc. Announces Executive Changes	19-03-04	CI
Deciphera Pharmaceuticals, Inc. Announces Resignation of Liam Ratcliffe from the Board of Directors	19-02-22	CI
Deciphera Pharmaceuticals Appoints Daniel C. Martin as Chief Commercial Officer	18-09-18	CI
Deciphera Pharmaceuticals, Inc. Appoints Stephen B. Ruddy as Chief Technical Officer	18-05-29	CI
Deciphera Pharmaceuticals Elects Steven Hoerter to its Board of Director	18-05-21	CI
Deciphera Pharmaceuticals Appoints Christopher J. Morl as Chief Business Officer	16-10-06	CI
Deciphera Pharmaceuticals, LLC Appoints Two New Directors	16-10-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Deciphera Pharmaceuticals, Inc.

Equities

DCPH

US24344T1016

Insiders

Filters